Cramer recommends holding Crane as a strong company. Crane closed its acquisition of Precision Sensors & Instrumentation. Texas Instruments saw a slight drop in share price. Catalyst Pharmaceuticals exceeded earnings expectations and raised sales guidance. Crane's shares rose 0.9% on the latest trading day.
- Crane Company had impressive Q1 results with adjusted EPS of $1.22, 5% core sales growth, and raised full-year guidance. - They announced the acquisition of CryoWorks for $61 million, expanding their cryogenic product portfolio. - The aerospace and electronics segment continues to show strong demand with solid aftermarket sales and supply chain challenges. - Price Impact Rating: bullish - Impact Horizon Rating: short-term - Type: Earnings
- Crane (CR) has a history of beating earnings estimates. - Recent quarters show significant earnings surprises. - Positive Earnings ESP and Zacks Rank indicate possible future earnings beat. - Analysts have become bullish, expecting another beat. - The next earnings report is set to be released on April 22, 2024. Price Impact Rating: Bullish Impact Horizon Rating: Short-term Type: Research Analysis